Tower Research Capital LLC (TRC) - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 1 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$149,525
+88.6%
14,517
+201.8%
0.01%
+66.7%
Q2 2023$79,268
+226380.0%
4,810
+24.8%
0.00%
+200.0%
Q1 2023$35
-22.2%
3,854
-38.3%
0.00%
-50.0%
Q4 2022$45
-99.9%
6,250
-56.5%
0.00%
+100.0%
Q3 2022$72,000
+620.0%
14,364
+236.6%
0.00%
Q2 2022$10,000
-65.5%
4,267
+1.8%
0.00%
Q1 2022$29,000
-81.8%
4,191
-78.8%
0.00%
-100.0%
Q4 2021$159,000
+165.0%
19,770
+225.1%
0.00%
+50.0%
Q3 2021$60,000
+3.4%
6,082
-28.4%
0.00%0.0%
Q2 2021$58,000
+114.8%
8,497
+186.4%
0.00%
Q1 2021$27,000
-73.5%
2,967
-80.5%
0.00%
-100.0%
Q4 2020$102,000
+85.5%
15,246
+39.4%
0.00%
+200.0%
Q3 2020$55,000
+1733.3%
10,937
+1329.7%
0.00%
Q3 2019$3,000
-62.5%
765
-70.7%
0.00%
-100.0%
Q2 2019$8,0002,614
+1554.4%
0.00%
Q1 2019$0158
-10.2%
0.00%
Q4 2018$0
-100.0%
176
-98.2%
0.00%
-100.0%
Q1 2018$71,000
+3450.0%
9,740
+5222.4%
0.01%
Q4 2017$2,000
-93.9%
183
-94.3%
0.00%
-100.0%
Q3 2017$33,000
-35.3%
3,186
-30.6%
0.00%
-50.0%
Q2 2017$51,000
+2450.0%
4,593
+1687.2%
0.01%
Q1 2017$2,0002570.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,409,289$24,815,67612.25%
Knoll Capital Management, LLC 600,000$6,180,0006.42%
Vivo Capital, LLC 4,096,428$42,193,2084.62%
GENDELL JEFFREY L 5,615,350$57,838,1053.29%
Tri Locum Partners LP 983,602$10,131,1013.24%
Samsara BioCapital, LLC 967,527$9,965,5283.05%
MPM BioImpact LLC 664,224$6,841,5071.83%
COWEN AND COMPANY, LLC 2,338,302$24,084,5101.68%
RTW INVESTMENTS, LP 7,136,415$73,505,0751.55%
TANG CAPITAL MANAGEMENT LLC 1,000,000$10,300,0001.45%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders